These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17566122)

  • 1. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).
    Allen R
    Sleep Med; 2004 Jul; 5(4):385-91. PubMed ID: 15222997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome: pathophysiology and the role of iron and folate.
    Patrick LR
    Altern Med Rev; 2007 Jun; 12(2):101-12. PubMed ID: 17604457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron dextran for severe refractory restless legs syndrome.
    Ondo WG
    Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The restless legs syndrome.
    Barrière G; Cazalets JR; Bioulac B; Tison F; Ghorayeb I
    Prog Neurobiol; 2005 Oct; 77(3):139-65. PubMed ID: 16300874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome.
    Oertel WH; Trenkwalder C; Zucconi M; Benes H; Borreguero DG; Bassetti C; Partinen M; Ferini-Strambi L; Stiasny-Kolster K
    Mov Disord; 2007; 22 Suppl 18():S466-75. PubMed ID: 17516455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.
    Earley CJ; B Barker P; Horská A; Allen RP
    Sleep Med; 2006 Aug; 7(5):458-61. PubMed ID: 16740411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restless legs syndrome].
    Lai SC; Chen RS
    Acta Neurol Taiwan; 2008 Mar; 17(1):54-65. PubMed ID: 18564830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF iron, ferritin and transferrin levels in restless legs syndrome.
    Mizuno S; Mihara T; Miyaoka T; Inagaki T; Horiguchi J
    J Sleep Res; 2005 Mar; 14(1):43-7. PubMed ID: 15743333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is ferroportin-hepcidin signaling altered in restless legs syndrome?
    Clardy SL; Wang X; Boyer PJ; Earley CJ; Allen RP; Connor JR
    J Neurol Sci; 2006 Sep; 247(2):173-9. PubMed ID: 16759669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome.
    Allen RP
    Am J Med; 2007 Jan; 120(1 Suppl 1):S13-21. PubMed ID: 17198766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for restless legs syndrome.
    Fulda S; Wetter TC
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):537-52. PubMed ID: 16083328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome.
    Ekbom K; Ulfberg J
    J Intern Med; 2009 Nov; 266(5):419-31. PubMed ID: 19817966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome.
    Wang X; Wiesinger J; Beard J; Felt B; Menzies S; Earley C; Allen R; Connor J
    J Neurol Sci; 2004 May; 220(1-2):59-66. PubMed ID: 15140607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary restless legs syndrome].
    Oka Y; Ioue Y
    Brain Nerve; 2009 May; 61(5):539-47. PubMed ID: 19514514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic augmentation of restless legs syndrome.
    García-Borreguero D; Williams AM
    Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting.
    Molokwu OC
    Ann Pharmacother; 2008 May; 42(5):627-32. PubMed ID: 18381842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.